WHWK
Whitehawk Therapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$4.60
−0.65%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-43.6%
Return on equity
-41.2%
Return on assets
-47.0%
Return on invested capital
0.00x
Asset turnover
-$69.3M
Cash from operations
$3.33
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026